Turning multi-omics complexity into clear clinical decisions

newGenia transforms DNA, RNA, and proteomics into interactive clinical reports—linking each conclusion to the underlying evidence—so teams can move from data to treatment decisions faster.

With experience from

655402c8c51f63b83dcc9b68_PNG_HealthInc _ Final 2
655402c8c51f63b83dcc9b68_PNG_HealthInc _ Final 2
655402c8c51f63b83dcc9b68_PNG_HealthInc _ Final 2
655402c8c51f63b83dcc9b68_PNG_HealthInc _ Final 2
655402c8c51f63b83dcc9b68_PNG_HealthInc _ Final 2

Trusted by clinical teams

We at Sanquin have now fully integrated newGenia’s AI-powered multi-omics platform into our workflow for complex genomic cases. Analysis that once took weeks now takes hours, with every recommendation backed by transparent, traceable evidence. This speeds delivery to clinicians and builds confidence in results, making the platform an indispensable part of our precision diagnostics pipeline.

Clinical Genetics Lead

Partner Clinic / Lab

We built newGenia to answer the questions that slow clinicians down: what to test, what a variant means, and what changes in management. The platform keeps the reasoning visible—so results are actionable, not just technical.

Shahan Khan

Chief Technology Officer

newGenia turns data into clinical decisions

An end-to-end platform that supports test selection, interpretation, and ongoing re-interpretation. Built to fit real clinical and lab workflows.

Where newGenia delivers impact

Phenotype-to-gene prioritization

Match clinical history and phenotype to likely genes with linked citations.

Functional confirmation (RNA/Protein)

Confirm whether a DNA finding has real functional impact using RNA and proteomics.

Guideline-based variant classification

Score and rank variants using ACMG/European guidance with supporting studies attached.

Clinician-ready case report

Deliver an interactive report that summarizes evidence, conclusions, and next steps for clinical decision-making.

Molecular tumor subtyping

Integrate multi-omics signals to classify tumors and stratify patients beyond histology.

Functional confirmation (RNA)

Validate whether prioritized DNA variants affect expression or splicing with targeted RNA analysis.

Actionable variant interpretation

Score and rank key tumor variants using clinical guidelines, with linked supporting studies.

Pathway-guided therapy roadmap

Use proteomics-based pathway mapping to support targeted therapy selection with clearer rationale.

Inherited risk triage

Assess whether the presentation is likely driven by inherited genetics—so you know when genetic testing is warranted.

Cited testing rationale

Provide traceable citations to the scientific literature so test orders are easier to justify and communicate.

Phenotype-to-gene shortlisting

Match clinical history and phenotype to gene–phenotype associations to focus the right genes, panels, and targets early.

Medical necessity validation

Validate the clinical need for requested genetic tests to support consistent reimbursement review when required.

Continuous monitoring

Automatically scans new research, clinical trials, and variant databases as the science evolves.

Actionable change alerts

Sends clear notifications when new findings impact a patient’s existing variants—so teams can react in time.

Automated variant reclassification

Re-evaluates existing variants and updates status when evidence changes (e.g., VUS → Pathogenic/Benign).

Updated report export

Export the latest interpretation so it can be reviewed with a clinician and used for next steps.

From sample to insight - at scale

Handle higher volumes effortlessly

Automate key steps in multi-omics interpretation so your team can process more cases without increasing workload or headcount.

Keep decisions evidence-backed

Interpret results in a consistent, traceable way—linking each finding to guidelines, citations, and underlying phenotype-to-gene evidence.

Reduce turnaround from weeks to hours

Streamline interpretation and reporting so results reach clinicians faster—helping teams act without unnecessary delays.

Stay ahead with the latest science

Continuous re-interpretation alerts you when new research changes what a variant means—so prior cases remain clinically current.

Meet our team

newGenia is built by clinicians, molecular genetics experts, and engineers focused on making genomic intelligence usable in everyday care—secure, modular, and designed to fit real workflows.